WILMINGTON, MA — Below are some of the newest job openings in Wilmington:Part-Time Customer Service Representative at Lapels Dry CleaningFull-Time Field Technician at Northland Industrial Truck CompanyFull-Time Claims Administrator at Ametros Financial CorporationFull-Time Delivery Driver at Pepsi Co.Full-Time Certified Electrician at SunRunFull-Time Construction Professional at Response Team 1Full-Time Water Mitigation Technician at Response Team 1Part-Time Security Guard at Allied UniversalFull-Time Payroll Coordinator at UniFirstFull-Time Digital Marketing Specialist at Charles River Labs(NOTE: Wilmington businesses — Feel free to send me your job postings at firstname.lastname@example.org.)Like Wilmington Apple on Facebook. Follow Wilmington Apple on Twitter. Follow Wilmington Apple on Instagram. Subscribe to Wilmington Apple’s daily email newsletter HERE. Got a comment, question, photo, press release, or news tip? Email email@example.com.Share this:TwitterFacebookLike this:Like Loading… RelatedNOW HIRING: 10 Job Openings In WilmingtonIn “Business”NOW HIRING: 10 New Job Openings In WilmingtonIn “Business”NOW HIRING: 10 New Job Openings In WilmingtonIn “Business”
Thalapathy Vijay in Sarkar.PR HandoutVamsi Paidipally’s Telugu movie Maharshi is rumoured to remade in Tamil soon. Ilayathalapathy Vijay is said to be playing the lead role essayed by superstar Mahesh Babu in the original version.The trend in India cinema is that some movies get huge demand for their remake rights after they register critical and commercial success. But it is a rare scene where a film gets it even before its release in the cinema halls. This feat is achieved Mahesh Babu’s Maharshi, which is scheduled for worldwide release on May 1. Thanks to the hype and curiosity generated by its promos.It rumoured that a not Kollywood producer is impressed with the songs, posters and teaser of Maharshi and he has approached the makers of the movie for its remake rights even before the film hit the screens. He is said to have planned to adopt this Telugu movie to Tamil with an A-list star in the lead role.It is known that Vijay has earlier acted in the Tamil remake of Mahesh Babu’s hit movies like Pokkiri and Okkadu. Like Prince, Thalapathy has been starring movies with a message to society for the last few years. Maharshi is also a message-oriented romantic action drama. Hence, Vijay is expected to act in Tamil remake of this film. It will be very interesting to see Vijay if he gives his consent for this project. Mahesh Babu in MaharshiTwitterVijay is currently busy shooting for his upcoming movie Thalapathy 63. He may not accept the remake of Maharshi for two reasons. Firstly, of late he has stopped acting in remakes, rather he is working with young directors, who are coming up with fresh scripts. Secondly, Mahesh has a good fanbase in Tamil Nadu and his 25th film will release in a good number of screens there. Hence there is no point in remaking it.Maharshi is produced by Dil Raju, C Ashwini Dutt and Prasad V Potluri under the banners Sri Venkateswara Creations, Vyjayanthi Movies and PVP Cinema. Mahesh Babu and Pooja Hegde are seen in the lead roles, while Allari Naresh and Ananya and Meenakshi Dixit essay in prominent roles in the movie, which has Devi Sri Prasad’s music and KU Mohanan’s cinematography.
A British Airways airplane flies past a signage of pharmaceutical giant GlaxoSmithKline (GSK) in London in this file photo. GlaxoSmithKline is said to have formed a separate team to chalk out aggressive acquisition plans to further its growth in the competitive Indian market. REUTERS/Luke MacGregorGlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time since it started its operations in the country 93 years ago, according to a Business Standard (BS) report on Monday.The change in strategy for a company which has preferred to rely on its traditional strengths in the branded generics space. The decision to grow inorganically comes at a time when the government is increasing price over branded generic medicines which has affected the company’s profitability.”So far, our inorganic growth in India has primarily been driven by global acquisition strategy,” Managing Director Annaswamy Vaidheesh told the financial daily.The firm has established products like Zinetac, used for acid peptic ulcer therapy, which have been included in the National List of Essential Medicines (NELM), and reduction of prices on these drugs has affected the firm’s margins.Since the NELM inclusion, Zinetac’s value has fallen 5 per cent, despite its volumes increasing 36 per cent, Business Standard said. Zinetac has market share of 47 per cent in the category, according to December 2016 data from IMS.The UK-headquartered company recorded compounded annual growth rate (CAGR) of a meagre 4.4 per cent to Rs 3,000 crore for 2016-17. Profit declined to Rs 337 crore in 2016-17 from Rs 429 crore in 2011. For the first quarter of fiscal 2018 ended June 30, 2017, net sales touched Rs 587 crore, with profits at Rs 26 crore. The company changed its financial year to March-ending in 2014-15 from December-ending earlier, the report said.Regulatory headwinds, eroded marginsDespite pricing headwinds propelled by the government’s social obligations finding their way into pharmaceutical policy, the firm has cemented its commitment to India by investing Rs 1,000 crore in a new manufacturing facility in Vemgal, Karnataka. Another Rs 500 crore is being spent for upgrading a facility in Nashik, near Pune. It is now bringing more products in areas of respiratory drugs and vaccines from its global pipeline to India, the BS report said.In 2015, the parent company, GlaxoSmithKline Plc, had swapped its marketed oncology portfolio with the vaccine business of Novartis AG, Switzerland. This involved the swapping of their businesses in India, too, the BS report said.The parent company got its current identity with the merger of Glaxo Wellcome with SmithKline Beecham in 2000.Vaidheesh said that it was only in the recent past that the company built a India team to evaluate inorganic growth opportunities in the domestic market. “Since we have got our manufacturing footprint more or less sorted, it is time for us to look at what else we can do to drive growth,” Vaidheesh told the financial daily. A woman walks past a GlaxoSmithKline Pharmaceuticals Ltd logo outside the company headquarters in Mumbai in this December 16, 2013 file photo. REUTERS/Danish SiddiquiRegulatory pressures on Indian pharmaceutical companies have been worsening by the day, accompanied by pricing pressure in the generics segment denting realisations.USFDA alerts on Indian pharma companies have increased over the past few years. Regulators used to visit the plants every two years. Now they come every eight months. Increasing inspections have led to a total of 41 import alerts in the past eight years, with 33 of them occurring in the 2013-16 period. This clearly signifies increased USFDA scrutiny on Indian pharma firms.
Election commission building. File PhotoTaking video or photograph of voting rooms in the upcoming general elections would be considered as criminal offences, an official of election commission (EC) said on Friday.EC joint secretary Md Qamrul Hasan told a function for trainees on parliamentary election at the Nirbachan Bhaban in the capital’s Agargaon area.“At first voters have to mention their identities after entering voting rooms. Presiding and other officials concerned will conduct voting process as per the electoral code of conduct for ensuring free, fair and neutral election,” he said.Qamrul said presiding officers would prevent any unfair practices in the voting rooms of the upcoming national election.The presiding officers in the polling centre would hand over the fake voters to the law enforcement personnel, he said adding fake voters will be given punishment through mobile courts.Highlighting electoral of code of conduct, he said, “Election observers would not stay in a polling centre for a long time. Presiding officers cannot give interview to the observers.”
Kolkata: The Central Bureau of Investigation (CBI) has interrogated suspended IPS officer Syed Md. Hussain Mirza on Thursday in connection with the Narada sting operation case. He was interrogated earlier but due some ambiguities found in his statement, he was summoned again.On Thursday, the 2004 batch IPS officer was grilled for almost seven hours by the CBI sleuths. According to sources, he was questioned again why he had taken the money from Mathew Samuels. He was also asked if he had taken the money on behalf of someone else. Also Read – Rs 13,000 crore investment to provide 2 lakh jobs: MamataAccording to CBI sources, he had cooperated with the sleuths while recording of his statement on Thursday. He was repeatedly asked about a former Member of Parliament (MP) who had later joined BJP, as Mirza was known to be close to the MP before he was suspended. The former MP was seen in the footage saying that the Superintendent of Police (SP), Burdwan received the money. But he had not made it clear on whose behalf the then Burdwan SP Mirza received the money. Previously, Mirza had been interrogated by both CBI and Enforcement Directorate (ED) in connection with the Narada case. It has been alleged that he was seen receiving money in the footage, sitting at the Burdwan SP’s bungalow. Sources have informed that he may be called again if needed by the CBI.
This story originally appeared on PCMag February 21, 2019 Nike’s new basketball smart shoes are apparently bricking due to a faulty firmware update.Android users who bought the Nike Adapt BB are taking to the Google Play Store to complain. “Right shoe won’t connect after update and battery dies within a couple of hours,” reads one review for the Nike Adapt app, which connects to the shoe.”Broke my $350 shoes with a Nike update,” reads another review.It isn’t clear how widespread the problem is for Android users; currently, Google Play shows 18 largely poor reviews for the app, all related to the update issues. But those appeared right after the shoes launched over the weekend.Nike didn’t immediately respond to a request for comment. However, the firmware update problems don’t appear to affect the iOS version of the Nike Adapt app, which has mostly positive reviews.The Nike Adapt BBs have generated hype for the footwear’s self-lacing system. Each sneaker can sense your foot’s measurements and automatically tighten around it as you play a game of basketball for a perfect fit. To do that, this so-called “power lacing” system needs the Nike Adapt app and battery power. Nike plans to issue routine firmware updates to support its cutting-edge basketball shoes, though the updates are intended to be opt-in, Nike said last month.Despite the faulty update, owners can still wear the Nike Adapt BBs without the app, but they’ll just be regular sneakers. To fix the problem, users are reporting you can try initiating a factory reset. One owner managed to resolve the issues by activating the shoes using his wife’s iPhone. This hands-on workshop will give you the tools to authentically connect with an increasingly skeptical online audience. Free Workshop | August 28: Get Better Engagement and Build Trust With Customers Now 2 min read Enroll Now for Free